Foundayo vs Mounjaro for Weight Loss: Results, Doses and Key Differences

A daily weight-loss tablet or a weekly injection may sound like a simple choice, but the differences go much deeper. In the Foundayo vs Mounjaro comparison, Foundayo contains orforglipron and is taken orally each day, whereas Mounjaro contains tirzepatide and is administered as a once-weekly injection. Their mechanisms, dosing schedules and clinical evidence for weight loss also differ.

Both treatments are designed to support medically managed weight loss, yet they do not deliver identical results. Mounjaro has demonstrated greater average weight reduction in separate clinical trials, while Foundayo offers a needle-free approach. Comparing their effectiveness, dosing, side effects and suitability can help explain where each treatment may fit.

GLP-1 / GIP

Mounjaro

Dual-agonist support that helps curb appetite, hunger, and cravings to drive substantial, sustained weight loss.

• ✔ ~22.5% average body weight loss
• ✔ Significant weight reduction
• ✔ Improves blood sugar levels
• ✔ Clinically proven weight loss

START FREE CONSULTATION

Key takeaways: Foundayo vs Mounjaro

• Mounjaro showed greater average weight loss in its 72-week trial, although the results cannot be treated as a direct head-to-head comparison.
• Foundayo is a daily oral treatment, while Mounjaro is administered as a once-weekly injection.
• Both treatments can cause digestive side effects, including nausea, diarrhoea, vomiting, constipation and abdominal pain.
• Their milligram strengths are not directly comparable, as they contain different active ingredients and work through different hormonal pathways.
• Individual suitability matters, including treatment preferences, medical history, other medicines, previous response and ability to follow the dosing routine.
• A qualified prescriber should guide the final choice, considering both the available evidence and your individual treatment needs.

What do Foundayo and Mounjaro have in common?

Foundayo and Mounjaro differ in how they are taken, but they share several features as prescription treatments for weight management. Both are developed by Eli Lilly and are intended to support eligible adults alongside appropriate dietary and lifestyle changes.

Key similarities include:

• Appetite regulation: Both treatments act on hormonal pathways involved in appetite, helping reduce hunger and promote feelings of fullness.
• Gradual dose increases: Treatment begins at a lower strength before progressing through higher doses according to the recommended dosing schedule and individual response.
• Weight-management support: Both are designed for adults who meet the relevant prescribing criteria for medical weight management.
• Lifestyle changes remain important: Neither treatment replaces nutrition, physical activity and other sustainable lifestyle measures.
• Ongoing treatment: Both are intended to support longer-term weight management when treatment remains appropriate, effective and well tolerated.
• Clinical monitoring: Suitability, treatment response and side effects should be reviewed by a healthcare professional as treatment progresses.

Foundayo vs Mounjaro: What are the key differences?

The difference between Foundayo and Mounjaro goes beyond choosing a tablet or an injection. Foundayo contains orforglipron, a GLP-1 receptor agonist, while Mounjaro contains tirzepatide, which acts on both GIP and GLP-1 receptors. Their formulations, dosing schedules and administration also create noticeably different treatment routines.

Beyond these practical differences, their position within UK weight-management treatment also varies. Foundayo was authorised by the MHRA for weight management in August 2026, while Mounjaro is recommended by NICE for eligible adults under defined NHS criteria.

The listed milligram strengths do not indicate which treatment is stronger. Orforglipron and tirzepatide are different medicines, so clinical weight-loss results provide a more meaningful basis for comparing their effectiveness.

Find Out If Mounjaro is Clinically Suitable

• Clinician-led medical assessment
• Personalised dosing and nutrition support
• Ongoing clinical monitoring throughout treatment

Start Your Free Consultation Now

Foundayo vs Mounjaro: Which is more effective for weight loss?

Both Foundayo and Mounjaro have produced substantial weight loss in clinical studies, but Mounjaro achieved the larger average reduction at the higher doses studied. The results need careful interpretation, however, because the medicines were evaluated in separate trials rather than tested directly against each other.

What weight loss was achieved with Foundayo?

In the 72-week ATTAIN-1 trial, 3,127 adults with obesity and without type 2 diabetes received orforglipron or placebo alongside lifestyle measures. At the highest dose studied in the trial, 36 mg orforglipron resulted in an average body-weight reduction of 12.4% based on the efficacy estimand.

Among participants receiving this dose:

• 59.6% lost at least 10% of their body weight
• 39.6% lost at least 15%
• 20.1% lost at least 20%

These findings demonstrate the weight-loss potential of orforglipron, although the 36 mg dose evaluated in ATTAIN-1 should not be confused with the current Foundayo dosing strengths.

What weight loss was achieved with Mounjaro?

SURMOUNT-1 followed 2,539 adults with obesity, or overweight with at least one weight-related condition, who did not have type 2 diabetes. Participants received tirzepatide or placebo alongside lifestyle intervention for 72 weeks.

Average body-weight reductions based on the efficacy estimand reached 16.0% with 5 mg, 21.4% with 10 mg and 22.5% with 15 mg tirzepatide. This shows that the amount of weight lost increased across the doses evaluated in the study.

Does this mean Mounjaro works better than Foundayo?

The available trial results favour Mounjaro for average weight reduction at the higher doses evaluated. However, these percentages come from different clinical trials with separate participant groups and should not be treated as a direct measure of superiority.

Individual results can also vary according to factors such as treatment response, dose tolerance and adherence. A direct head-to-head trial would provide stronger evidence for determining how Foundayo and Mounjaro compare when evaluated under the same study conditions.

Do Foundayo and Mounjaro have the same side effects?

Foundayo and Mounjaro share several digestive side effects, although their overall safety profiles are not identical. Both can cause nausea, diarrhoea, vomiting, constipation and abdominal pain, particularly as the body adjusts to treatment. The frequency and severity of these effects can vary between individuals.

What should you watch out for?

• Dehydration: Persistent vomiting or diarrhoea can cause fluid loss, making adequate hydration important.
• Severe abdominal pain: Persistent, severe abdominal pain may indicate acute pancreatitis and requires urgent medical attention.
• Low blood sugar: The risk of hypoglycaemia can increase when either treatment is combined with certain diabetes medicines, including insulin or sulfonylureas.
• Gallbladder problems: Symptoms such as persistent upper abdominal pain, jaundice or fever should be medically assessed.
• Injection-site reactions: Redness or itching may occur around the Mounjaro injection site.
• Individual tolerance: Side effects vary between people, so it is not possible to predict which treatment will be better tolerated by an individual.

Side-effect rates should not be directly compared between Foundayo and Mounjaro because available figures may come from separate clinical trials with different participants and reporting methods. For complete safety information, known side effects and their frequency, refer to the Foundayo Patient Information Leaflet and Mounjaro Patient Information Leaflet.

Foundayo or Mounjaro: What should you consider?

Choosing between Foundayo and Mounjaro is not only about expected weight loss. Foundayo may suit people who prefer a needle-free daily tablet, while Mounjaro may appeal to those comfortable with a once-weekly injection. Dosing routine, travel, storage and ability to stay consistent with treatment can also influence the choice.

Medical history, other medicines, previous treatment response and side-effect tolerance should also be considered. As individual needs and preferences can change, the most effective option is not automatically the most suitable. A prescriber can weigh these factors alongside clinical evidence to determine which treatment is appropriate for you.

Conclusion: Choosing a Treatment That Fits

The Foundayo vs Mounjaro choice extends beyond which treatment achieved greater average weight loss in clinical trials. Their differences in effectiveness, treatment routine and practical use mean the decision should consider more than clinical results alone.

Ultimately, suitability needs to be assessed on an individual basis. At Mayfair Weight Loss Clinic, you can complete an online consultation for review by a qualified prescriber, who can assess your medical history, treatment needs and suitability before recommending an appropriate weight-loss treatment.

FAQs about Foundayo vs Mounjaro

Can Foundayo and Mounjaro be taken together?

Foundayo and Mounjaro should not be combined unless a qualified prescriber specifically recommends this. They are separate prescription weight-loss treatments, and using both without medical guidance could increase the risk of side effects.

Can you switch from Mounjaro to Foundayo?

Switching from Mounjaro to Foundayo may be appropriate for some people, but the change should be planned by a prescriber. They can consider your current dose, treatment response, side effects and medical history before recommending how to switch.

Can you switch from Foundayo to Mounjaro?

Some people may be able to switch from Foundayo to Mounjaro when clinically appropriate. Your prescriber should determine the timing and dosing rather than you changing treatments independently.

Can Foundayo be used for type 2 diabetes?

Yes. Foundayo is authorised for adults with type 2 diabetes as well as weight management. It is used alongside appropriate diet and exercise when additional treatment is considered suitable.

Can Mounjaro be used without diabetes?

Yes. Mounjaro can be prescribed for weight management in eligible adults who do not have type 2 diabetes. Suitability depends on individual health circumstances and applicable prescribing criteria.

Does Foundayo need to be taken with food?

No. Foundayo can be taken once daily without specific food or water restrictions. Follow the instructions provided with your prescription and patient information leaflet.

What should you do if you miss a Foundayo dose?

If you miss a Foundayo dose, follow the instructions provided with your medicine and do not take more than the recommended daily dose. If you are unsure what to do, ask your pharmacist or prescriber.

What should you do if you miss a Mounjaro dose?

If a Mounjaro dose is missed, the action depends on how much time has passed. Follow the missed-dose instructions provided with your medicine and never take a double dose to make up for a missed injection.